Trial intelligence / Profile preview

Doxycycline in Aggressive Periodontitis

NCT03727620Phase 2Completed

Sponsor
Mohammed V University
Start
Jan 2014
Primary completion
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of doxycycline in Aggressive Periodontitis (AP) (2 arms), sponsored by Mohammed V University. Primary endpoint: Decrease of periodontal pockets ≥ 4mm. Started Jan 2014; status: completed.

02

Drugs

doxycycline
03

Conditions

Aggressive Periodontitis (AP)

Beyond the preview

Go deeper on NCT03727620.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03727620.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call